CPA3
Mast cell carboxypeptidase A
Also known as: CBPA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15088
- Gene
- CPA3
- Ensembl
- ENSG00000163751
- Chromosome
- 3
- Canonical length
- 417 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the carboxypeptidase A family of zinc metalloproteases. The encoded preproprotein is proteolytically processed to generate a mature protease that is released by mast cells and may be involved in the degradation of endogenous proteins and the inactivation of venom-associated peptides. Expression of this gene may be elevated in human asthma patients. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
417 residues, UniProt reviewed canonical sequence.
>P15088|CPA3
1 MRLILPVGLI ATTLAIAPVR FDREKVFRVK PQDEKQADII KDLAKTNELD FWYPGATHHV
61 AANMMVDFRV SEKESQAIQS ALDQNKMHYE ILIHDLQEEI EKQFDVKEDI PGRHSYAKYN
121 NWEKIVAWTE KMMDKYPEMV SRIKIGSTVE DNPLYVLKIG EKNERRKAIF TDCGIHAREW
181 VSPAFCQWFV YQATKTYGRN KIMTKLLDRM NFYILPVFNV DGYIWSWTKN RMWRKNRSKN
241 QNSKCIGTDL NRNFNASWNS IPNTNDPCAD NYRGSAPESE KETKAVTNFI RSHLNEIKVY
301 ITFHSYSQML LFPYGYTSKL PPNHEDLAKV AKIGTDVLST RYETRYIYGP IESTIYPISG
361 SSLDWAYDLG IKHTFAFELR DKGKFGFLLP ESRIKPTCRE TMLAVKFIAK YILKHTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- gallbladder: 105 nTPM
- lung: 81 nTPM
- cervix: 56 nTPM
- rectum: 53 nTPM
- urinary bladder: 50 nTPM
- small intestine: 43 nTPM
Single-cell type
- mast cells: 3,889 nCPM
- megakaryocyte progenitors: 167 nCPM
- megakaryocyte-erythroid progenitors: 126 nCPM
- hematopoietic stem cells: 28 nCPM
- pancreatic acinar cells: 10 nCPM
- pdcs: 7.3 nCPM
Immune cell
- basophil: 1,120 nTPM
- total PBMC: 2.9 nTPM
- eosinophil: 0.7 nTPM
- neutrophil: 0.4 nTPM
- non-classical monocyte: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- basal ganglia: 0.9 nTPM
- choroid plexus: 0.7 nTPM
- thalamus: 0.2 nTPM
- medulla oblongata: 0.1 nTPM
- amygdala: 0 nTPM
- cerebellum: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.69
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPA3 as an antibody target. Whether an autoantibody or antibody against CPA3 could matter depends on whether native CPA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CPA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...